Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity

James M. Ntambi,Makoto Miyazaki,Jonathan P. Stoehr,Hong Lan,Christina M. Kendziorski,Brian S. Yandell,Yang Song,Paul Cohen,Jeffrey M. Friedman,Alan D. Attie
DOI: https://doi.org/10.1073/pnas.132384699
IF: 11.1
2002-08-12
Proceedings of the National Academy of Sciences
Abstract:Stearoyl–CoA desaturase (SCD) is a central lipogenic enzyme catalyzing the synthesis of monounsaturated fatty acids, mainly oleate (C18:1) and palmitoleate (C16:1), which are components of membrane phospholipids, triglycerides, wax esters, and cholesterol esters. Several SCD isoforms ( SCD1 - 3 ) exist in the mouse. Here we show that mice with a targeted disruption of the SCD1 isoform have reduced body adiposity, increased insulin sensitivity, and are resistant to diet-induced weight gain. The protection from obesity involves increased energy expenditure and increased oxygen consumption. Compared with the wild-type mice the SCD1 −/− mice have increased levels of plasma ketone bodies but reduced levels of plasma insulin and leptin. In the SCD1 −/− mice, the expression of several genes of lipid oxidation are up-regulated, whereas lipid synthesis genes are down-regulated. These observations suggest that a consequence of SCD1 deficiency is an activation of lipid oxidation in addition to reduced triglyceride synthesis and storage.
What problem does this paper attempt to address?